{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:46:18Z","timestamp":1791776778722,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T00:00:00Z","timestamp":1507161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T00:00:00Z","timestamp":1507161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Carbapenemase-producing Enterobacteriaceae (CPE) are emerging worldwide, limiting therapeutic options. Mutational and plasmid-mediated mechanisms of colistin resistance have both been reported. The emergence and clonal spread of colistin resistance was analysed in 40 epidemiologically-related NDM-1 carbapenemase producing <jats:italic>Klebsiella pneumoniae<\/jats:italic> isolates identified during an outbreak in a group of London hospitals. Isolates from July 2014 to October 2015 were tested for colistin susceptibility using agar dilution, and characterised by whole genome sequencing (WGS). Colistin resistance was detected in 25\/38 (65.8%) cases for which colistin susceptibility was tested. WGS found that three potential mechanisms of colistin resistance had emerged separately, two due to different mutations in <jats:italic>mgrB<\/jats:italic>, and one due to a mutation in <jats:italic>phoQ<\/jats:italic>, with onward transmission of two distinct colistin-resistant variants, resulting in two sub-clones associated with transmission at separate hospitals. A high rate of colistin resistance (66%) emerged over a 10 month period. WGS demonstrated that mutational colistin resistance emerged three times during the outbreak, with transmission of two colistin-resistant variants.<\/jats:p>","DOI":"10.1038\/s41598-017-12637-4","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T17:28:37Z","timestamp":1506706117000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Emergence and clonal spread of colistin resistance due to multiple mutational mechanisms in carbapenemase-producing Klebsiella pneumoniae in London"],"prefix":"10.1038","volume":"7","author":[{"given":"Jonathan A.","family":"Otter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Doumith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Mookerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Dyakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gilchrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eimear T.","family":"Brannigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Bamford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Galletly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Aanensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Ellington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5652-6472","authenticated-orcid":false,"given":"Jane F.","family":"Turton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie L.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Woodford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,5]]},"reference":[{"key":"12637_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/cid\/cit795","volume":"58","author":"MJ Schwaber","year":"2014","unstructured":"Schwaber, M. J. & Carmeli, Y. An ongoing national intervention to contain the spread of carbapenem-resistant Enterobacteriaceae. Clin Infect Dis \n                           58, 697\u2013703 (2014).","journal-title":"Clin Infect Dis"},{"key":"12637_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","volume":"18","author":"R Canton","year":"2012","unstructured":"Canton, R. et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect \n                           18, 413\u2013431 (2012).","journal-title":"Clin Microbiol Infect"},{"key":"12637_CR3","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3201\/eid2007.121004","volume":"20","author":"ME Falagas","year":"2014","unstructured":"Falagas, M. E., Tansarli, G. S., Karageorgopoulos, D. E. & Vardakas, K. Z. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis \n                           20, 1170\u20131175 (2014).","journal-title":"Emerg Infect Dis"},{"key":"12637_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cmi.2016.10.005","volume":"23","author":"JA Otter","year":"2017","unstructured":"Otter, J. A. et al. Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective. Clin Microbiol Infect \n                           23, 188\u2013196 (2017).","journal-title":"Clin Microbiol Infect"},{"key":"12637_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004129","volume":"4","author":"ES Snitkin","year":"2012","unstructured":"Snitkin, E. S. et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med \n                           4, 148ra116 (2012).","journal-title":"Sci Transl Med"},{"key":"12637_CR6","doi-asserted-by":"crossref","unstructured":"Monaco, M. et al. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill \n                           19 (2014).","DOI":"10.2807\/1560-7917.ES2014.19.42.20939"},{"key":"12637_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijantimicag.2014.02.016","volume":"44","author":"YM Ah","year":"2014","unstructured":"Ah, Y. M., Kim, A. J. & Lee, J. Y. Colistin resistance in Klebsiella pneumoniae. Int J Antimicrob Agents \n                           44, 8\u201315 (2014).","journal-title":"Int J Antimicrob Agents"},{"key":"12637_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/cid\/ciu213","volume":"59","author":"RL Nation","year":"2014","unstructured":"Nation, R. L., Velkov, T. & Li, J. Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese? Clin Infect Dis \n                           59, 88\u201394 (2014).","journal-title":"Clin Infect Dis"},{"key":"12637_CR9","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1128\/JCM.01017-15","volume":"53","author":"T Giani","year":"2015","unstructured":"Giani, T. et al. Large Nosocomial Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae Traced to Clonal Expansion of an mgrB Deletion Mutant. J Clin Microbiol \n                           53, 3341\u20133344 (2015).","journal-title":"J Clin Microbiol"},{"key":"12637_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijantimicag.2015.02.015","volume":"46","author":"A Jayol","year":"2015","unstructured":"Jayol, A., Poirel, L., Villegas, M. V. & Nordmann, P. Modulation of mgrB gene expression as a source of colistin resistance in Klebsiella oxytoca. Int J Antimicrob Agents \n                           46, 108\u2013110 (2015).","journal-title":"Int J Antimicrob Agents"},{"key":"12637_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/jac\/dku323","volume":"70","author":"L Poirel","year":"2015","unstructured":"Poirel, L. et al. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother \n                           70, 75\u201380 (2015).","journal-title":"J Antimicrob Chemother"},{"key":"12637_CR12","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1093\/jac\/dkv118","volume":"70","author":"C Formosa","year":"2015","unstructured":"Formosa, C., Herold, M., Vidaillac, C., Duval, R. E. & Dague, E. Unravelling of a mechanism of resistance to colistin in Klebsiella pneumoniae using atomic force microscopy. J Antimicrob Chemother \n                           70, 2261\u20132270 (2015).","journal-title":"J Antimicrob Chemother"},{"key":"12637_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ijantimicag.2014.07.020","volume":"44","author":"AO Olaitan","year":"2014","unstructured":"Olaitan, A. O. et al. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP\/PhoQ regulator mgrB: an epidemiological and molecular study. Int J Antimicrob Agents \n                           44, 500\u2013507 (2014).","journal-title":"Int J Antimicrob Agents"},{"key":"12637_CR14","doi-asserted-by":"publisher","first-page":"5696","DOI":"10.1128\/AAC.03110-14","volume":"58","author":"A Cannatelli","year":"2014","unstructured":"Cannatelli, A. et al. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother \n                           58, 5696\u20135703 (2014).","journal-title":"Antimicrob Agents Chemother"},{"key":"12637_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","volume":"16","author":"Y-Y Liu","year":"2015","unstructured":"Liu, Y.-Y. et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis \n                           16, 161\u2013168 (2015).","journal-title":"Lancet Infect Dis"},{"key":"12637_CR16","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1128\/AAC.01075-16","volume":"60","author":"V Di Pilato","year":"2016","unstructured":"Di Pilato, V. et al. MCR-1.2: a new MCR variant encoded by a transferable plasmid from a colistin-resistant KPC carbapenemase-producing Klebsiella pneumoniae of sequence type 512. Antimicrob Agents Chemother \n                           60, 5612\u20135615 (2016).","journal-title":"Antimicrob Agents Chemother"},{"key":"12637_CR17","unstructured":"Rojas, L. J. et al. Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality. Clin Infect Dis (2016)."},{"key":"12637_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep38511","volume":"6","author":"XP Li","year":"2016","unstructured":"Li, X. P. et al. Clonal spread of mcr-1 in PMQR-carrying ST34 Salmonella isolates from animals in China. Sci Rep \n                           6, 38511 (2016).","journal-title":"Sci Rep"},{"key":"12637_CR19","doi-asserted-by":"crossref","unstructured":"Xavier, B. B. et al. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill \n                           21 (2016).","DOI":"10.2807\/1560-7917.ES.2016.21.27.30280"},{"key":"12637_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/jam.13169","volume":"121","author":"J Osei Sekyere","year":"2016","unstructured":"Osei Sekyere, J., Govinden, U., Bester, L. A. & Essack, S. Y. Colistin and tigecycline resistance in carbapenemase-producing Gram-negative bacteria: emerging resistance mechanisms and detection methods. J Applied Microbiol \n                           121, 601\u2013617 (2016).","journal-title":"J Applied Microbiol"},{"key":"12637_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S1473-3099(16)00056-6","volume":"16","author":"H Du","year":"2016","unstructured":"Du, H., Chen, L., Tang, Y. W. & Kreiswirth, B. N. Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae. Lancet Infect Dis \n                           16, 287\u2013288 (2016).","journal-title":"Lancet Infect Dis"},{"key":"12637_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S1473-3099(16)00057-8","volume":"16","author":"X Yao","year":"2016","unstructured":"Yao, X., Doi, Y., Zeng, L., Lv, L. & Liu, J. H. Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1. Lancet Infect Dis \n                           16, 288\u2013289 (2016).","journal-title":"Lancet Infect Dis"},{"key":"12637_CR23","doi-asserted-by":"publisher","first-page":"6837","DOI":"10.1128\/AAC.01344-16","volume":"60","author":"T Halaby","year":"2016","unstructured":"Halaby, T. et al. Genomic Characterization of Colistin Heteroresistance in Klebsiella pneumoniae during a Nosocomial Outbreak. Antimicrob Agents Chemother \n                           60, 6837\u20136843 (2016).","journal-title":"Antimicrob Agents Chemother"},{"key":"12637_CR24","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.1128\/AAC.01480-13","volume":"57","author":"A Cannatelli","year":"2013","unstructured":"Cannatelli, A. et al. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ\/PhoP mgrB regulator. Antimicrob Agents Chemother \n                           57, 5521\u20135526 (2013).","journal-title":"Antimicrob Agents Chemother"},{"key":"12637_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jinf.2016.10.002","volume":"74","author":"A Oliva","year":"2017","unstructured":"Oliva, A. et al. Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp). J Infect \n                           74, 103\u2013106 (2017).","journal-title":"J Infect"},{"key":"12637_CR26","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","volume":"13","author":"LS Munoz-Price","year":"2013","unstructured":"Munoz-Price, L. S. et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis \n                           13, 785\u2013796 (2013).","journal-title":"Lancet Infect Dis"},{"key":"12637_CR27","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1126\/science.276.5310.250","volume":"276","author":"L Guo","year":"1997","unstructured":"Guo, L. et al. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science \n                           276, 250\u2013253 (1997).","journal-title":"Science"},{"key":"12637_CR28","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.1128\/AAC.05391-11","volume":"55","author":"AK Miller","year":"2011","unstructured":"Miller, A. K. et al. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients. Antimicrob Agents Chemother \n                           55, 5761\u20135769 (2011).","journal-title":"Antimicrob Agents Chemother"},{"key":"12637_CR29","doi-asserted-by":"crossref","unstructured":"Han, J. H. et al. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Network of Long-Term Acute Care Hospitals. Clin Infect Dis (2016).","DOI":"10.1093\/cid\/ciw856"},{"key":"12637_CR30","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1128\/AAC.00952-15","volume":"59","author":"MJ Choi","year":"2015","unstructured":"Choi, M. J. & Ko, K. S. Loss of hypermucoviscosity and increased fitness cost in colistin-resistant Klebsiella pneumoniae sequence type 23 strains. Antimicrob Agents Chemother \n                           59, 6763\u20136773 (2015).","journal-title":"Antimicrob Agents Chemother"},{"key":"12637_CR31","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1128\/AAC.01064-12","volume":"56","author":"ZZ Deris","year":"2012","unstructured":"Deris, Z. Z. et al. The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic\/pharmacodynamic model. Antimicrob Agents Chemother \n                           56, 5103\u20135112 (2012).","journal-title":"Antimicrob Agents Chemother"},{"key":"12637_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/srep28168","volume":"6","author":"JH Chung","year":"2016","unstructured":"Chung, J. H., Bhat, A., Kim, C. J., Yong, D. & Ryu, C. M. Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii. Sci Rep \n                           6, 28168 (2016).","journal-title":"Sci Rep"},{"key":"12637_CR33","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1128\/JCM.00545-15","volume":"53","author":"R Onori","year":"2015","unstructured":"Onori, R. et al. Tracking Nosocomial Klebsiella pneumoniae Infections and Outbreaks by Whole-Genome Analysis: Small-Scale Italian Scenario within a Single Hospital. J Clin Microbiol \n                           53, 2861\u20132868 (2015).","journal-title":"J Clin Microbiol"},{"key":"12637_CR34","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.diagmicrobio.2013.02.006","volume":"76","author":"MH Al-Agamy","year":"2013","unstructured":"Al-Agamy, M. H. et al. Persistence of Klebsiella pneumoniae clones with OXA-48 or NDM carbapenemases causing bacteraemias in a Riyadh hospital. Diag Microbiol Infect Dis \n                           76, 214\u2013216 (2013).","journal-title":"Diag Microbiol Infect Dis"},{"key":"12637_CR35","unstructured":"PHE. Acute trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae. https:\/\/www.gov.uk\/government\/publications\/carbapenemase-producing-enterobacteriaceae-early-detection-management-and-control-toolkit-for-acute-trusts [Accessed 02\/08\/2017] (2013)."},{"key":"12637_CR36","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jhin.2015.08.007","volume":"92","author":"APR Wilson","year":"2016","unstructured":"Wilson, A. P. R. et al. Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party. J Hosp Infect \n                           92, S1\u2013S44 (2016).","journal-title":"J Hosp Infect"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12637-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12637-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12637-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:47:44Z","timestamp":1671796064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12637-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,5]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["12637"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-12637-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,5]]},"assertion":[{"value":"12 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JAO is a consultant to Gama Healthcare. MG attended a Pfizer advisory board in 2015. All other authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12711"}}